Atlas Trials

Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer

Clinical trial NCT04217057 · TERMINATED

Trial details

NCT number
NCT04217057
Sponsor
Washington University School of Medicine
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2020-02-07
Primary completion
2023-02-07
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.